Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

BerGenBio - Filing #5877180

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
1,254,000 NOK
431,000 NOK
Current assets
154,543,000 NOK
173,904,000 NOK
Non-current liabilities
818,000 NOK
0 NOK
Current liabilities
32,277,000 NOK
46,859,000 NOK
Revenue
848,000 NOK
354,000 NOK
Profit (loss)
139,282,000 NOK
139,282,000 NOK
190,401,000 NOK
190,401,000 NOK
Comprehensive income
0 NOK
140,531,000 NOK
0 NOK
0 NOK
140,531,000 NOK
0 NOK
0 NOK
189,234,000 NOK
189,234,000 NOK
0 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.